MedPath

吉林巨仁堂药业股份有限公司

Ownership
-
Established
1999-05-18
Employees
-
Market Cap
-
Website
www.jljrt.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

45

NMPA:45

Drug Approvals

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H22022159
Approval Date
Apr 30, 2020
NMPA

Choline Magnesium Trisalicylate Tablets

Product Name
三水杨酸胆碱镁片
Approval Number
国药准字H22024932
Approval Date
Apr 30, 2020
NMPA

Compound Paracetamol and Diphenhydramine Hydrochloride Tablets

Product Name
复方氨酚苯海拉明片
Approval Number
国药准字H22025547
Approval Date
Apr 30, 2020
NMPA

复方茶碱麻黄碱片

Approval Number
国药准字H22025983
Approval Date
Apr 30, 2020
NMPA

Isopropiram Fumarate Tablets

Product Name
富马酸异丙吡仑片
Approval Number
国药准字H22025568
Approval Date
Apr 30, 2020
NMPA

Vitamin U, Aluminium Hydroxide and Magnesium Trisilicate Capsules

Product Name
维U颠茄铝镁胶囊
Approval Number
国药准字H22024023
Approval Date
Apr 30, 2020
NMPA

Chlobamolie Hydrochloride Tablets

Product Name
盐酸妥洛特罗片
Approval Number
国药准字H22024397
Approval Date
Apr 30, 2020
NMPA

Vitamin E Nicotinicate Capsules

Product Name
维生素E烟酸酯胶囊
Approval Number
国药准字H22024024
Approval Date
Apr 30, 2020
NMPA

Compound Gentian and Sodium Bicarbonate Tablets

Product Name
复方龙胆碳酸氢钠片
Approval Number
国药准字H22024019
Approval Date
Apr 30, 2020
NMPA

Compound Phenytoin Sodium,Ephedrin Hydrochloride and Theophylline Tablets

Product Name
复方妥英麻黄茶碱片
Approval Number
国药准字H22024020
Approval Date
Apr 30, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.